Stocktoria
Pediatrix Medical Group, Inc. MD
Pediatrix Medical Group, Inc. (MD) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the grey zone. It does not currently pay a dividend. FY2025 revenue was $1.9B at a 8.6% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · grey zone
| Component | Value |
|---|---|
| Working capital / assets | 0.136 |
| Retained earnings / assets | -0.037 |
| EBIT / assets | 0.093 |
| Equity / liabilities | 0.627 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| MD | Pediatrix Medical Group, Inc. | 6/9 | 2.05 | 12.3 | -4.9% |
| JRSS | JRSIS HEALTH CARE Corp | 6/9 | -7.26 | — | — |
| SEM | SELECT MEDICAL HOLDINGS CORP | 5/9 | 1.45 | 14 | +5.1% |
| EHC | Encompass Health Corp | 7/9 | — | 17.8 | +10.5% |
| GOOG | Alphabet Inc. | 5/9 | 6.79 | 31.1 | +15.1% |
| MSFT | MICROSOFT CORP | 6/9 | 4.49 | 20.7 | +17.8% |
| META | Meta Platforms, Inc. | 4/9 | 5.34 | 23.1 | +22.2% |
About Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
FAQ
Is MD financially healthy?
Pediatrix Medical Group, Inc.'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the grey zone.
Does MD pay a dividend?
No, Pediatrix Medical Group, Inc. does not currently pay a dividend.
How profitable is MD?
In FY2025, Pediatrix Medical Group, Inc. had a net margin of 8.6% and a return on equity of 19.1%.
Is MD overvalued or undervalued?
Pediatrix Medical Group, Inc. trades at about 13.7× trailing earnings — below its 10-year norm (10-year range 11.0×–21.3×, median 19.4×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for MD?
The average Wall-Street price target for Pediatrix Medical Group, Inc. is $23.17, about 12.6% below the recent price, from 6 analysts (consensus: buy).
Is MD a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Pediatrix Medical Group, Inc.: a Piotroski F-score of 6/9, an Altman Z″ in the grey zone, a P/E of about 12.3×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.